Site Content

---

Fluorescent-Guided Surgical Resection of Glioma with Targeted Molecular Imaging Agents: A Literature Review.

Craig SEL, Wright J, Sloan AE, Brady-Kalnay SM.

World Neurosurg. 2016 Jun;90:154-163. doi: 10.1016/j.wneu.2016.02.060. Epub 2016 Feb 23.

PMID: 26915698 Free PMC article. Review.

Single cell molecular recognition of migrating and invading tumor cells using a targeted fluorescent probe to receptor PTPmu.

Burden-Gulley SM, Qutaish MQ, Sullivant KE, Tan M, Craig SE, Basilion JP, Lu ZR, Wilson DL, Brady-Kalnay SM.

Int J Cancer. 2013 Apr 1;132(7):1624-32. doi: 10.1002/ijc.27838. Epub 2012 Oct 11.

PMID: 22987116 Free PMC article.

Novel cryo-imaging of the glioma tumor microenvironment reveals migration and dispersal pathways in vivid three-dimensional detail.

Burden-Gulley SM, Qutaish MQ, Sullivant KE, Lu H, Wang J, Craig SE, Basilion JP, Wilson DL, Brady-Kalnay SM.

Cancer Res. 2011 Sep 1;71(17):5932-40. doi: 10.1158/0008-5472.CAN-11-1553. Epub 2011 Aug 23.

PMID: 21862632 Free PMC article.

A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu.

Burden-Gulley SM, Gates TJ, Burgoyne AM, Cutter JL, Lodowski DT, Robinson S, Sloan AE, Miller RH, Basilion JP, Brady-Kalnay SM.

Neoplasia. 2010 Apr;12(4):305-16. doi: 10.1593/neo.91940.

PMID: 20360941 Free PMC article.

Quantitative Molecular Imaging with a Single Gd-Based Contrast Agent Reveals Specific Tumor Binding and Retention in Vivo.

Johansen ML, Gao Y, Hutnick MA, Craig SEL, Pokorski JK, Flask CA, Brady-Kalnay SM.

Anal Chem. 2017 Jun 6;89(11):5932-5939. doi: 10.1021/acs.analchem.7b00384. Epub 2017 May 22.

PMID: 28481080 Free PMC article.

Molecular Imaging of Tumors Using a Quantitative T 1 Mapping Technique via Magnetic Resonance Imaging.

Herrmann K, Johansen ML, Craig SE, Vincent J, Howell M, Gao Y, Lu L, Erokwu B, Agnes RS, Lu ZR, Pokorski JK, Basilion J, Gulani V, Griswold M, Flask C, Brady-Kalnay SM.

Diagnostics (Basel). 2015;5(3):318-32. doi: 10.3390/diagnostics5030318.

PMID: 26435847 Free PMC article.

Molecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.

Burden-Gulley SM, Zhou Z, Craig SE, Lu ZR, Brady-Kalnay SM.

Transl Oncol. 2013 Jun 1;6(3):329-37. doi: 10.1593/tlo.12490. Print 2013 Jun.

PMID: 23730413 Free PMC article.

Detection of Tumor-Specific PTPmu in Gynecological Cancer and Patient Derived Xenografts.Vincent J, Craig SEL, Johansen ML, Narla J, Avril S, DiFeo A, Brady-Kalnay SM.Diagnostics (Basel). 2021 Jan 27;11(2):181. doi: 10.3390/diagnostics11020181.PMID: 33513911 Free PMC article.

A PTPmu Biomarker is Associated with Increased Survival in Gliomas.

Johansen ML, Vincent J, Gittleman H, Craig SEL, Couce M, Sloan AE, Barnholtz-Sloan JS, Brady-Kalnay SM. Int J Mol Sci. 2019 May 14;20(10):2372. doi: 10.3390/ijms20102372.

PMID: 31091655 Free PMC article.

Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents.

Johansen ML, Perera R, Abenojar E, Wang X, Vincent J, Exner AA, Brady-Kalnay SM.

Int J Mol Sci. 2021 Feb 17;22(4):1983. doi: 10.3390/ijms22041983.

PMID: 33671448 Free PMC article.

PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma.

Covarrubias G, Johansen ML, Vincent J, Erokwu BO, Craig SEL, Rahmy A, Cha A, Lorkowski M, MacAskill C, Scott B, Gargesha M, Roy D, Flask CA, Karathanasis E, Brady-Kalnay SM.

Nanomedicine. 2020 Aug;28:102216. doi: 10.1016/j.nano.2020.102216. Epub 2020 May 13.

PMID: 32413511 Free PMC article.

Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.

Peiris PM, Abramowski A, Mcginnity J, Doolittle E, Toy R, Gopalakrishnan R, Shah S, Bauer L, Ghaghada KB, Hoimes C, Brady-Kalnay SM, Basilion JP, Griswold MA, Karathanasis E.

Cancer Res. 2015 Apr 1;75(7):1356-65. doi: 10.1158/0008-5472.CAN-14-1540. Epub 2015 Jan 27.

PMID: 25627979 Free PMC article.